IPO Pro - "The Ultimate Resource for IPOs"
Don't risk buying another IPO without IPO Pro.
Get your FREE TRIAL now.
Phase 2 biotech developing DMT-based therapies for depression.
Industry: Health Care
Latest Trade: $10.66 -0.05 (-0.5%)
First Day Return: +20.3%
Return from IPO: -33.1%
Industry: Health Care
IPO Data | |
---|---|
IPO File Date | 06/04/2021 |
Offer Price | $16.00 |
Price Range $14.00 - $16.00 | |
Offer Shares (mm) | 10.0 |
Deal Size ($mm) | $160 |
Lock-Up Date | IPO Pro Only |
Street Research | IPO Pro Only |
IPO Data | |
---|---|
IPO Date | 06/24/2021 |
Offer Price | $16.00 |
Price Range $14.00 - $16.00 | |
Offer Shares (mm) | 10.0 |
Deal Size ($mm) | $160 |
Lock-Up Date | IPO Pro Only |
Street Research | IPO Pro Only |
Underwriters |
---|
TD Cowen |
Stifel |
more |
Company Data | |
---|---|
Headquarters | Dublin, Ireland |
Founded | 2018 |
Employees | 8 |
Website www.ghres.com |